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Only patients in Ivabradine demonstrated further improvement in LVESVi
(73  15 ml/m2 to 62  15 ml/m2, p = 0.001), LVEDVi (103  19 ml/
m2 to 95  18 ml/m2, p = 0.001), MPI (23% vs 2.7%, p = 0.001), LVEF
(29  3.6 to 34.5  5.4%, p = 0.001) and LVGlobal Strain (13.3  1.6 to
20.2  4.4%, p = 0.001) while those in the control group did not
show any further change. Parameters like E/A, E/A VTI, MPI, E/E'
septal and E/E' lateral showed sustained improvement at 6months only in
the ivabradine group – E/A (1.5  0.5 to 1.1  0.3, p = 0.001), E/A VTI
(1.6  0.5 to 1.1  0.3, p = 0.001), E/e' septal (11.6  3.3 to 9.5  2.2,
p = 0.001), E/e' lateral (11.6  3.2 to 9.8  2.5, p = 0.001).
On multivariate analysis, heart rate reduction was a stronger pre-
dictor of improvement in LVEF ( p = 0.03) than ivabradine treatment
( p = 0.5). Change in HR signiﬁcantly correlated with improvement
in NYHA class (r = +0.4, p = 0.01), fall in BNP levels (r = 0.4,
p = 0.001), better EF (r = 0.38, p = 0.001) and reduction in global
LV strain (r = +0.28, p = 0.03) at 6 months.
Conclusion: Ivabradine added to standard therapy in patients of
DCM with chronic HF produces greater % change in all assessed
parameters including functional class and echocardiographic
parameters especially global LV strain. Ivabradine therapy was
four times more likely to result in HR reduction to <70 bpm at 6
months. Heart rate manipulation with ivabradine may play an
important role in the management of such patients.
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A 24-year-old male patient presented with mild epigastric pain for
2 days and fever for one week. Electrocardiogram of the patient
was suggestive of ventricular tachycardia with a heart rate of 200/
min. Immediately, the patient was injected IV amiodarone 150 mg
as bolus dose. The patient became dyspnoeic and developed frank
pulmonary edema after sometime and had to be managed with
mechanical ventilator support. 2D echocardiography suggestive of
dilated cardiomyopathy which reversed as the patient improved.
The brucella IgM antibodies titres were 3.51 (positive > 1.1). Dilated
cardiomyopathy was caused by Brucella myocarditis which led to
ventricular tachycardia on admission, cardiogenic shock with sub-
sequent development of pulmonary edema and acute renal failure.
The cardiogenic shock led to ischemic hepatitis which was possi-
bly accentuated further by the bolus dose of amiodarone. Thus,
ﬁnal diagnosis of Brucella myocarditis with ischemic hepatitis and
acute kidney injury was made.
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Background: The goal of this study was to evaluate if red cell
distribution width (RDW) can serve as a relatively inexpensive
diagnostic marker in cases of heart failure (HF) in India, where
diagnostic markers such as N Terminal-Pro Brain Natriuretic Pep-
tide (NTP BNP) are expensive.
Methods: This was an cross-sectional observational study con-
ducted from June 2012 to June 2014 in a tertiary care hospital, in
which participants aged ≥18 years, after informed consent was
divided into two groups: Cases – 100 patients with HF diagnosed on
the basis of clinical examination, X-ray chest and Echodoppler and
Controls – 100 patients without HF. Those with conditions which
elevate RDW like anemia, arthritis, neoplasia, hypothyroidism,
liver disease, and inﬂammatory bowel disease were excluded.
SYSMEX KX 21 Automated Hematology Analyserwas used to generate
the complete blood count (CBC) report from which RDW was
compared between the two groups to evaluate its utility as an
independent marker for HF.
Results: Out of the 100 patients of HF, 47 had HF with reduced
ejection fraction (HFREF) and 53 had HF with preserved ejection
fraction (HFPEF). Themean RDWwas signiﬁcantly higher in the HF
patients (53.85  5.39 ﬂ) than controls (42.21  1.66 ﬂ). It was also
found to be signiﬁcantly higher in both subgroups – HFREF (56.96
 5.18 ﬂ) and HFPEF (51.10  3.88 ﬂ) than that in controls. Using the
Spearman's Rho calculator, the value of ‘‘r’’ between RDW and
LVEF is 0.55996 and the two-tailed value of p is 0 which was
statistically signiﬁcant.
Conclusion: RDW is a readily available and relatively inexpensive
test which can be carried out in the HF-population. BothHFREF and
HFPEF patients were found to have signiﬁcantly higher RDW than
controls. Understanding how and why this marker is associated
with HF may provide novel insights into HF pathophysiology.
Further investigation is necessary to determine the pathological
mechanism of the relationship and its prognostic signiﬁcance.
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Introduction: Severe pulmonary artery hypertension (PAH) in
infants is rare presentation without congenital heart disease
(CHD). Cardiac beriberi is often a missed diagnosis and is still
common. Thiamine supplements in unexplained congestive heart
failure (CHF) with severe PAH in a patient from poor socio eco-
nomic (SE) status may be life saving.
Materials and methods: A total of 25 infants (male 18, female 7)
were found to have unexplained severe PAH during period of June
2012 to June 2015were included. All infantswere exclusively breast
fed belonging to low SE strata with their mothers from predomi-
nant rice eating population. Infants with CHD were excluded.
Presentation was poor feeding, excessive cry and/or respiratory
distress. 2D Echo done showed severe PAH and RV dysfunction in
all; 2 patients had associated pericardial and pleural effusion.
Diagnosis of cardiac beriberi was made and thiamine supplement
were started immediately. No other PAH medications were given.
Results:The average age of presentationwas 3.5months (range 1–6
months); weight 4.3 kg (2.8–6.5 kg). Arterial blood gas (ABG) analysis
showed high lactate levels (mean 6.4, range 3.4–17 mmol/l) at pre-
sentation. Mean PA pressures were 74 mmHg (range 50–110mmHg)
at admission. The lactate levels were higher in infants less than
three-month age (n = 10) when compared with older infants (n = 15)
between 3-month and 6-month age group (lactate 9.6 mmol/l vs
4.2 mmol/l respectively, p < 0.05). The infants presenting before
threemonths had severe CHF and two infants presentedwith acute
gasping state with severe lactic acidosis requiring mechanical ven-
tilation. The response of thiamine supplement was rapid, ABG
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